Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia
Status:
Terminated
Trial end date:
2020-03-29
Target enrollment:
Participant gender:
Summary
2019 new coronavirus (2019-nCoV) infected pneumonia, namely severe acute respiratory
infection (SARI) has caused global concern and emergency. There is a lack of effective
targeted antiviral drugs, and symptomatic supportive treatment is still the current main
treatment for SARI.
Vitamin C is significant to human body and plays a role in reducing inflammatory response and
preventing common cold. In addtion, a few studies have shown that vitamin C deficiency is
related to the increased risk and severity of influenza infections.
We hypothize that Vitamin C infusion can help improve the prognosis of patients with SARI.
Therefore, it is necessary to study the clinical efficacy and safety of vitamin C for the
clinical management of SARI through randomized controlled trials during the current epidemic
of SARI.